A
Ann L. Parke
Researcher at University of Connecticut Health Center
Publications - 20
Citations - 1044
Ann L. Parke is an academic researcher from University of Connecticut Health Center. The author has contributed to research in topics: Pregnancy & Disease. The author has an hindex of 10, co-authored 20 publications receiving 964 citations. Previous affiliations of Ann L. Parke include Saint Francis University.
Papers
More filters
Journal ArticleDOI
Anti-inflammatory and immunosuppressive drugs and reproduction.
Monika Østensen,Munther A. Khamashta,Michael D. Lockshin,Ann L. Parke,Antonio Brucato,Howard Carp,Andrea Doria,Raj Rai,Pier Luigi Meroni,Irene Cetin,Ronald H. W. M. Derksen,Ware Branch,Mario Motta,Caroline Gordon,Guillermo Ruiz-Irastorza,Arsenio Spinillo,Deborah I. Friedman,Rolando Cimaz,Andrew Czeizel,J.C. Piette,Ricard Cervera,Roger A. Levy,Maurizio Clementi,Sara De Carolis,Michelle Petri,Yehuda Shoenfeld,D Faden,Guido Valesini,Angela Tincani +28 more
TL;DR: Benefits of anti-inflammatory, immunosuppressive and biological drugs during pregnancy and lactation, effects of these drugs on male and female fertility and possible long-term effects on infants exposed to drugs antenatally are discussed.
Journal ArticleDOI
Pregnancy and reproduction in autoimmune rheumatic diseases
Monika Østensen,Antonio Brucato,Howard Carp,Christina D. Chambers,Radboud J E M Dolhain,Andrea Doria,Frauke Förger,Caroline Gordon,Sinuhe Hahn,Munther A. Khamashta,Michael D. Lockshin,Marco Matucci-Cerinic,Pier Luigi Meroni,J. Lee Nelson,Ann L. Parke,Michelle Petri,Luigi Raio,Guillermo Ruiz-Irastorza,Clovis A. Silva,Angela Tincani,Peter M. Villiger,Dorothea Wunder,Maurizio Cutolo +22 more
TL;DR: Pregnancies in patients with SLE are mostly successful when well planned and monitored interdisciplinarily, whereas a small proportion of women with APS still have adverse pregnancy outcomes in spite of the standard treatment.
Journal ArticleDOI
Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain
Steven E. Carsons,Frederick B. Vivino,Ann L. Parke,Nancy L. Carteron,Vidya Sankar,Richard Brasington,Michael T. Brennan,William H. Ehlers,Robert I. Fox,Hal Scofield,Katherine M. Hammitt,Julius Birnbaum,Stuart Kassan,Steven Mandel +13 more
TL;DR: The Sj Ögren's Syndrome Foundation clinical practice guidelines (CPGs) are designed to improve quality and consistency of care in Sjögren's syndrome by offering recommendations for management.
Journal ArticleDOI
Subclinical autoimmunity in recurrent aborters.
Donald Maier,Ann L. Parke +1 more
TL;DR: It is suggested that recurrent pregnancy loss may be a marker for subclinical autoimmune disease in women with habitual abortion.
Journal ArticleDOI
Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
St Clair Ew,Alan N. Baer,Chungwen Wei,Ghaith Noaiseh,Ann L. Parke,Andreea Coca,Tammy O. Utset,Mark C. Genovese,Daniel J. Wallace,James McNamara,Karen D. Boyle,Lynette Keyes-Elstein,Jeffrey L. Browning,Nathalie Franchimont,Smith K,Joel M. Guthridge,Iñaki Sanz,Judith A. James +17 more
TL;DR: Treatment with baminercept failed to significantly improve glandular and extraglandular disease in patients with primary SS, despite evidence from mechanistic studies showing that it blocks LTβR signaling.